By Fineline Cube 
China-based Contract Development and Manufacturing Organization (CDMO) Porton Advanced Solutions Ltd. and Cellstore announced today that they have entered into a strategic partnership focused on optimizing cell therapy drug cryopreservation technologies. The collaboration aims to facilitate domestic alternatives and enhance cost-efficiency, accelerating cell drug research, development, and manufacturing.
Collaboration Focus Areas
Under this partnership, Cellstore will provide Porton Advanced with precise, efficient, and safe cell cryopreservation solutions tailored for various cell types and compatible with automated production needs. This will support process upgrades for cell therapy drug development.
Addressing Cryopreservation Challenges
For difficult-to-cryopreserve samples and specific process requirements in cell therapy, both parties will jointly promote customized cryopreservation solution development services. They will also work together to facilitate excipient filing or FDA submissions, accelerating the market entry of cell therapy drugs.
Leveraging Strengths for Innovation
By leveraging their respective strengths, Porton Advanced and Cellstore will work together to achieve more efficient and safer sample storage management and process upgrades in cell therapy drug CDMO services. This collaboration aims to advance the development of innovative therapies and the industrialization and commercialization of cell therapy drugs.-Fineline Info & Tech